Arcus Biosciences RCUS
NYSE RCUS
$18.93 +0.65 (+3.56%)
At close: Nov 9, 2026 · 4:00 PM EST

Arcus Biosciences (RCUS) Non-Current Deferred Revenue (2017 - 2026)

Updated

Analysis

Arcus Biosciences (RCUS) Non-Current Deferred Revenue (2017 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,261.99 Bn 1,235.61 Bn 20.46 Bn
2 Johnson & Johnson 678.93 Bn 598.79 Bn 17.30 Bn
3 AbbVie 518.29 Bn 486.30 Bn 13.12 Bn
4 Merck 365.98 Bn 328.92 Bn 13.19 Bn
5 Novartis Ag 316.85 Bn 290.09 Bn -
6 Astrazeneca 293.40 Bn 267.29 Bn 13.26 Bn
7 Amgen 251.78 Bn 203.43 Bn 7.58 Bn
8 Gilead Sciences 210.61 Bn 185.71 Bn 6.73 Bn
9 Pfizer 166.87 Bn 114.23 Bn 12.56 Bn
10 Arcus Biosciences 2.42 Bn -713.13 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 34.00 Mn
Jun 30, 2026 37.00 Mn
Mar 31, 2026 45.00 Mn
Dec 31, 2025 43.00 Mn
Sep 30, 2025 53.00 Mn
Jun 30, 2025 60.00 Mn
Mar 31, 2025 219.00 Mn
Dec 31, 2024 234.00 Mn
Sep 30, 2024 289.00 Mn
Jun 30, 2024 214.00 Mn
Mar 31, 2024 242.00 Mn
Dec 31, 2023 307.00 Mn
Sep 30, 2023 326.00 Mn
Jun 30, 2023 330.00 Mn
Mar 31, 2023 330.00 Mn
Dec 31, 2022 355.00 Mn
Sep 30, 2022 382.58 Mn
Jun 30, 2022 429.34 Mn
Mar 31, 2022 456.91 Mn
Dec 31, 2021 462.00 Mn
API Access

Arcus Biosciences Non-Current Deferred Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-current-deffered-revenue&ticker=RCUS&period=max&api_key=YOUR_API_KEY